Showing results (191-200 of 198) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Infection|July 1, 1995
A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once dailyH Bassaris, E Akalin, S Calangu, et al.Molecular Cell|July 21, 2001
Cooperation between STAT3 and c-jun suppresses Fas transcriptionV N Ivanov, A Bhoumik, M Krasilnikov, et al.The Quarterly Journal of Medicine|April 1, 1987
Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) JewsA Zimran, B Rudensky, M R Kramer, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmentR Finch, D Schürmann, O Collins, et al.The Journal of Biological Chemistry|February 6, 1999
The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3O W Nadeau, P Domanski, A Usacheva, et al.The Plant Cell|August 1, 1990
Expression of a maize cell wall hydroxyproline-rich glycoprotein gene in early leaf and root vascular differentiationV Stiefel, L Ruiz-Avila, R Raz, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 20, 2012
Bacteriological aspects of Darier's diseaseR Dodiuk-Gad, E Cohen-Barak, M Ziv, et al.Lancet (London, England)|October 30, 1999
Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study GroupN Bisharat, V Agmon, R Finkelstein, et al.Pageof 20